Clinical presentation, pathophysiology, diagnostic procedures and therapeutic strategies in progressive-systemic sclerosis [PSS] with gastrointestinal involvement;Klinik, Pathophysiologie, Diagnostik und Therapie gastrointestinaler Manifestationen der progressiv-systemischen Sklerodermie (PSS)

Zeitschrift fur Gastroenterologie

Volumn 34, Issue 8, 1996, Pages 497-508

  Folwaczny, C ^a   Voderholzer, W ^a   Riepl, R L ^a   Schindlbeck, N ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

bacterial overgrowth; gastroesophageal reflux; gastrointestinal involvement; intestinal pseudoobstruction; manometry; octreotide; progressive systemic sclerosis; prokinetic drugs; scintigraphy

Indexed keywords

ANORECTAL PRESSURE; BACTERIAL OVERGROWTH; BARIUM ENEMA; CLINICAL FEATURE; CONSTIPATION; DIARRHEA; ESOPHAGUS PRESSURE; HUMAN; HYDROGEN BREATH TEST; INTESTINE INNERVATION; MALNUTRITION; MANOMETRY; NEUROPATHY; REFLUX ESOPHAGITIS; REVIEW; SCREENING TEST; STEATORRHEA; STOMACH PARESIS; SYSTEMIC SCLEROSIS;

DIGESTIVE SYSTEM; ENTERIC NERVOUS SYSTEM; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL DISEASES; GASTROINTESTINAL TRANSIT; HUMANS; INTESTINAL PSEUDO-OBSTRUCTION; MANOMETRY; REFERENCE VALUES; SCLERODERMA, SYSTEMIC;

EID: 0029784889     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (119)

1. Russel ML, Friesen D, Henderson RD, Hann WM. Ultrastructure of the esophagus in scleroderma. Arthritis Rheum 1982; 25: 1117-23
2. Dessein PH, Joffe BI, Metz RM et al. Autonomic dysfunction in systemic sclerosis: sympathetic overactivity and instability. Am J Med 1992; 93: 143-50
3. Silver RM. Clinical aspects of systemic sclerosis (scleroderma). Ann Rheum Dis 1991; 50 (suppl. 4): 854-61
4. Boyd JA, Patrick SI, Reeves RJ. Roentgen changes observed in generalized scleroderma: report of sixty-three cases. Arch Intern Med 1954; 94: 248
5. Cohen S. Motor disorders of the esophagus. N Engl J Med 1979; 301: 184-92
6. Harper RA, Jackson DC. Progressive systemic sclerosis. Br J Radiol 1965; 38: 825
7. Hoskins LC, Norris HT, Gottlieb LS. Functional and morphologic alterations of the gastrointestinal tract in progressive systemic sclerosis (scleroderma). Am J Med 1962; 33: 459-70
8. Rankin BG, Poirier TJ Gastrointestinal manifestations of progressive systemic scleroderma. Gut 1969; 12: 30-44
9. Peachey DGR, Creamer B, Pierce JW. Sclerodermatous involvement of the stomach and the small and large bowel. Gut 1969; 10: 285-92
10. Sjøgren RW. Gastrointestinal motility disorders in scleroderma. Arthritis Rheum 1994; 9: 1265-82
11. Abu Shakra M, Guillemin F, Lee P. Gastrointestinal manifestations of systemic sclerosis. Sem Arthr Rheum 1994; 24: 29-39
12. Battle WM, Snape WJ, Cohen S. Disordered colonic motility in scleroderma Clin Res 1979; 27: 577 A
13. Hamel-Roy J, Devroede G, Arhan P et al. Comparative esophageal and anorectal motility in scleroderma. Gastroenterology 1985, 88: 1-7
14. D'Angelo AW, Fries FJ, Masi TA, Shuman EL. Pathologic observations in systemic sclerosis (scleroderma). Am J Med 1969; 46: 428-40
15. Kemp-Harper RA, Jackson DC. Progressive systemic sclerosis. Br J Radiol 1965; 38: 825-34
16. Olmstedt WW, Madewell JE. The esophageal and small bowel manifestations of progressive systemic sclerosis. Gastrointest Radiol 1976; 1: 33-6
17. Maddern J, Horowitz M, Jamieson BC, Collins P, Roberts-Thomson P. Abnormalities of esophageal and gastric emptying in progressive systemic sclerosis Gastroenterobgy 1984. 87; 4: 922-6
18. Bortolotti M, Turba E, Tosti A et al. Gastric emptying and interdigestive antroduodenal motility in patients with esophageal scleroderma. Am J Gastroenterol 1991; 86: 743-7
19. McBrien DJ, Lockhart-Mummery HE. Steatorrhea in progressive systemic sclerosis. Br Med J 1962; 2: 1653-6
20. Horswell RR, Hargrove DM, Peete WP, Ruffin MJ. Scleroderma presenting as the malabsorption syndrome. Gastroenterology 1961, 40: 580-2
21. Kahn IL, Jeffries GH, Sleisenger MH. Malabsorption in scleroderma: correction by antibiotics. N Engl J Med 1966; 274: 1339-44
22. Greenberger JN, Dobbins OW, Ruppert DR, Jesseph EJ. Intestinal atony in progressive systemic sclerosis (scleroderma). Am J Med 1968; 45: 301-8
23. Rosson RS, Yesner R. Peroral duodenal biopsy in progressive systemic sclerosis. N Engl J Med 1965; 272: 391-4
24. Goldgraber MD, Kirsner JB. Scleroderma of the gastrointestinal tract. Arch Pathol 1957, 64: 255-65
25. Dewey MM. The anatomical basis of propagation in smooth muscle. Gastroenterology 1965, 49: 395
26. Blom-Bulow B, Sundstrom G, Johnson B, Tylen U, Wollheim F. Early changes in oesophageai function in progressive systemic sclerosis: a comparison of manometry and radiology. Clin Physiol 1984; 4: 147-58
27. Park RHR, McKillopp JH, Belch JJF, Faichney A, MacKenzie JF. Achalasia-like syndrome in systemic sclerosis. Br J Surg 1990: 77: 46-9
28. Bortolloti M, Pinotti R, Sarti P, Barbara L. Esophageal electromyography in scleroderma patients with functional dysphagia. Am J Gastroenterol 1989; 84: 1497-502
29. Cohen S, Fischer R, Lipshutz W. The pathogenesis of esophageal dysfunction in scleroderma and Raynaud's disease. J Clin invest 1972; 51 2663-8
30. Cohen S, Laufer I, Snape JW et al. The gastrointestinal manifestations of scleroderma: pathogenesis and management. Gastroenterology 1980; 79: 155-66
31. Zamost BJ, Hirschberg J, Ippoliti AF et al. Esophagitis in scleroderma. prevalence and risk factors. Gastroenterology 1987; 92: 421-8
32. Tolin RD, Malmud LS, Reilley J, Fisher RS. Esophageal scintigraphy to quantitate esophageal transit. Gastroenteroiogy 1979; 76: 1402-8
33. Blackwell JN, Hannan WJ, Adam RD, Heading CR. Radionuclide transit studies in the detection of esophageal dysmotility. Gut 1983; 24: 421-6
34. Turner R, Lipshutz W, Miller W et al. Esophageal dysfunction in collagen disease. Am J Med Sci 1973, 265. 191-9
35. Murphy JR, MacNally P, Peller P, Shay SS. Prolonged clearance is the primary abnormal reflux parameter in patients with progressive systemic sclerosis and esophagitis. Dig Dis Sci 1992; 37: 833-41
36. Geppert T. Clinical features, pathogenic mechanisms and new development in the treatment of systemic sclerosis. Am J Med Sci 1990, 299. 193-209
37. Katzka DA, Reynolds JC, Saul SH et al. Barrett's metaplasia and adenocarcinoma of the esophagus in scleroderma. Am J Med 1987; 82: 46-52
38. Madsen JL, Hendl L. Gastrointestinal transit times of radiolabeled meal in progressive systemic sclerosis. Dig Dis Sci 1989: 37: 1404-8
39. Wegener M, Adamek RJ, Wedmann B, Jergas M, Altmeyer P. Gastrointestinal transit through esophagus, stomach, small and large intestine in patients with progressive systemic sclerosis. Dig Dis Sci 1994; 39: 2209-15
40. Folwaczny C, Hundegger K, Volger C et al. Measurement of transit disorders in different gastrointestinal segments in patients with diabetes mellitus in relation to duration and severity of the disease by use of the metal detector test. Z Gastroenterol 1995; 33 517-26
41. Folwaczny C, Volger C, Sorodoc J et al. Gastric emptying and small and large intestinal transit tn diabetes mellitus: influence of type, duration and severity of disease. In: Singer MV. Ziegler R, Rohr G (eds) Gastrointestinal tract and endocrine system, Lancaster (UK), Kluwer Academic Publisher, 1995. 315-9
42. Di Marino JA, Carlson G, Myers A, Schumacher RH, Cohen S. Duodenal myoelectric activity in scleroderma. N Engl J Med 1973; 289: 1220-3
43. Camillieri M, Malagelada JL. Abnormal intestinal motility in diabetics with the gastroparesis syndrome. Eur J Clin Invest 1984; 14: 420-7
44. Greydanus MP, Camilien M. Abnormal postcibal antral and small bowel motility due to neuropathy or myopathy in systemic sclerosis. Gastroenterology 1989; 96. 110-5
45. Vantrappen G, Janssens J, Hellemans J, Ghoos Y The interdigestive motor complex of normal subjects and patients with bacterial overgrowth of the small intestine. J Clin Invest 1977; 59: 1158-66
46. Code CE, Schlegel JF. The gastrointestinal interdigestive house-keeper: motor correlates of the interdigestive myoelectric complex of the dog. Proceedings of the fourth international symposium on gastrointestinal motility. Daniel EE, Bowes K, Gilbert JAL et al (eds.). Vancouver, Mitchell Press, 1974
47. Szurzewski JH. A migrating myoelectric complex of the canine small intestine. Am J Physiol 1969; 217: 1757-63
48. Soudah HC, Hasler WL, Owyang C. Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma. N Engl J Med 1991; 21: 1461-7
49. Folwaczny C, Rothfuß U, Riepl RL et al. Gastrointestinal manifestations of progressive systemic sclerosis (PSS). Gut 1995, 37, suppl. 2, A1
50. Folwaczny C, Rothfuß U, Riepl RL et al. Gastrointestinale Beteiligung bei progressiv systemischer Sklerodermie (PSS). Z Gastroenterol 1995; 33: 654-61
51. Rees WDW, Leigh RJ, Christofides ND, Boom SR, Turnberg LA. Interdigestive motor activity in patients with systemic sclerosis. Gastroenterology 1982, 83: 575-80
52. Miercort DR, Merrill FG. Pneumatosis and pseudo-obstruction in scleroderma. Radiology 1969; 92: 359-62
53. Meihoff WE, Hirschfeld JS, Kern F. Small intestinal scleroderma with malabsorption and pneumatosis cystoides intestinalis. JAMA 1968; 204. 102-6
54. Horowitz AL, Meyers MA. The hide-bound small bowel of scleroderma: characteristic mucosal fold pattern. Am J Roentgenol 1973, 1A: 332-4
55. Queloz JM, Wolashin HJ. Sacculation of the small intestine in scleroderma Radiology 1972; 105: 513-5
56. Poirer TJ, Rankin GB. Gastrointestinal manifestations of progressive systemic scleroderma based on a review of 364 cases. Am J Gastroenterol 1972; 58: 30-44
57. Piper WN, Helwig EB. Progressive systemic sclerosis: Visceral manifestation in generalized scleroderma. Arch Dermatol Cytol 1955; 72: 535-46
58. Beigelman PM, Goldner F, Bayler TB. Progressive sclerosis (scleroderma) N Engl J Med 1953; 249: 45-58
59. Abrahams HL, Craies WH, Eaton J. Alimentary tract in disseminated scleroderma with emphasis on the small intestine. Arch Intern Med 1954; 94 61-81
60. Lundberg AC, Akesson A, Akesson B. Dietary intake and nutritional status in patients with systemic sclerosis. Ann Rheum Dis 1992, 51: 1143-8
61. Leneman F, Fierst S, Babriel JB, Ingegno AP Progressive systemic sclerosis of the intestine presenting as malabsorpton syndrome. Gastroenterology 1962; 42: 175-80
62. Salen G, Goldstein F, Wirts W. Malabsorption in intestinal scleroderma. Ann Intern Med 1965, 64, 4: 834-41
63. Alpert LI, Warner RR Systemic sclerosis, case presenting with tetracycline-responsive malabsorption syndrome Am J Med 1968; 45: 468-72
64. Bluestone R, MacMahon M, Dawson JM. Systemic sclerosis and small bowel involvement Gut 1969; 10: 185-93
65. Doig A, Girdwood RG. The absorption of folic acid and labelled cyanocobalamin in intestinal malabsorption. Q J Med 1960; 29: 333-74
66. Hendel L, Worning H. Exocrine pancreatic function in patients with systemic sclerosis Scand J Gastroenterol 1989; 24: 461-6
67. Kolodny M, Baker WG, CREST-syndrome with persistent gastrointestinal bleeding. Gastrointest Endosc 1968; 15: 16-7
68. Allende HD, Ona FW, Noronha AI. Bleeding gastric teleangiectasia. Am J Gastroenterol 1981; 75: 354-6
69. Gates C, Moand EE, Cavie P, Maddison PJ. Sclerotherapy as treatment of recurrent bleeding from upper gastrointestinal teleangiectasia in CREST-syndrome. Br J Rheumatol 1993; 32: 760-1
70. Battle WM, Snape WJ, Wright SA et al. Abnormal colonic motility in progressive systemic sclerosis. Ann intern Med 1981; 94: 749-52
71. Battle WM, McLean GK, Brooks JJ. Spontaneous perforation of the small intestine due to scleroderma. Dig Dis Sci 1979; 24: 80-4
72. Snape WJ, Matarazzo SA, Cohen S. Effect of eating and gastrointestinal hormones on human colonic motor activity. Gastroenterology 1978; 75: 373-8
73. Snape WJ, Wright SH, Battle WM, Cohen S. The gastrocolic response-evidence for a neuronal mechanism. Gastroenterology 1979; 77: 1235-40
74. Leighton JA, Valdovinos MA, Pemberton JH, Rath DM, Camilleri M. Anorectal dysfunction and rectal prolapse in progressive systemic sclerosis. Dis Colon Rectum 1993; 36: 182-5
75. Chiou AWH, Lin JK, Wang FM. Anorectal abnormalities in progressive sclerosis. Dis Colon Rectum 1989; 32: 417-21
76. Basilico G, Barbera R, Vanoli M, Bianchi P. Anorectal dysfunction and delayed colonic transit in patients with progressive systemic sclerosis. Dig Dis Sci 1993; 38, 8: 1525-9
77. Basilisco G, Barbera R, Vanoli M, Bianchi P. Delayed colonic transit in constipated patients with progressive systemic sclerosis (PSS) (abstract). Gastroenteroiogy 1992; 102: A421
78. Whitehead WE, Taitelbaum G, Wigley FM, Schuster MM. Rectosigmoid motility and myoelectric activity in progressive systemic sclerosis. Gastroenterology 1989; 96: 428-32
79. Laufer I, Clancy RI, Cockshott P. Diverticular fecalith in scleroderma simulating colonic neoplasm: report of a case. Dis Colon Rectum 1975; 18: 403-6
80. Skinner DB, Booth DJ. Assessment of distal esophageal function in patients with hiatal hernia and/or gastroesophageal reflux. Ann Surg 1970; 172: 627-31
81. Treacy LW, Baggenstoss HA, Slogumb HC, Code FC. Scleroderma of the esophagus Ann Intern Med 1963; 59: 351-6
82. Klein HA, Wald A, Graham TO, Campbell WL, Steen VD. Comparative studies of esophageal function in systemic sclerosis. Gastroenterology 1992; 102: 1551-6
83. Tatsch K, Schröttle W, Kirsch CM Multiple swallow test for the quantitative and qualitative evaluation. J Nucl Med 1991; 32: 1365-70
84. Stafford-Brady FJ, Kahn HJ, Ross TM, Russel ML. Advanced scleroderma bowel: complications and management. J Rheumatol 1988, 15: 869-74
85. Hinton JM, Lennard-Jones JE, Young AC. A new method for studying gut transit times using radiopaque markers. Gut 1969; 10: 842-7
86. Schindlbeck NE, Klauser AG, Müller-Lissner SA. Messung der Kolontransitzeit Z Gastroenterol 1990; 28: 399-404
87. Ewe K, Press AG, Dederer W. Gastrointestinal transit of undigestible solids measured by metal detector. Eur J Clin Invest 1989; 19: 291-7
88. Petrokubi RJ, Jeffries GH. Cimetidine versus antacid in scleroderma with reflux esophagitis: a randomized double-blind controlled study. Gastroenterology 1979; 77. 691-5
89. Hendel L, Aggestrup S, Stentoft P. Long-term ranitidine in progressive systemic sclerosis (scleroderma) with gastroesophageal reflux. Scand J Gastroenterol 1986, 21 799-805
90. Hendel L. Hydroxyproline in the oesophageal mucosa of patients with progressive systemic sclerosis during omeprazole induced healing of reflux oesophagitis. Aliment Pharmacol Ther 1991; 5: 471-80
91. Hendel L, Hage E, Hendel J, Stentoft P. Omeprazole in the long-term treatment of severe gastroesophageal reflux disease in patients with systemic sclerosis. Aliment Pharmacol Ther 1992; 6: 565-77
92. Olive A, Maddison PJ, Davis M Treatment of oesophagitis in scleroderma with omeprazole (letter). Br J Rheumatol 1989, 28 553
93. Kahan A, Chaussade S, Gaudric M et al. The effect of cisapride on gastro-oesophageal dysfunction in systemic sclerosis: a controlled manometnc study. Br J Clin Pharmacol 1991; 31: 683-7
94. Horowitz M, Maddern GJ, Madox A et al. Effects of cisapride on gastric and esophageal emptying in progressive systemic sclerosis Gastroenterology 1987; 93: 311-5
95. Ramirez B, Richter JB. Review article: promotility drugs in the treatment of gastroesophageal reflux disease. Aliment Pharmacol Ther 1993; 7: 5-20
96. Talley NJ Review article: 5-hydroxytryptamine agonists and antagonists in the modulation of gastrointestinal motility and sensation: clinical implications. Aliment Pharmacol Ther 1992; 6: 273-89
97. Ramirez-Mata M, Ibanez G, Alarzon Segovia D. Stimulatory effect of metoclopramide on the esophagus and lower esophageal sphincter of patients with PSS. Arthritis Rheum 1977; 20: 30-4
98. Corazziari E, Scopinaro F, Bontempo I. Effect of T51619 on distal oesophageal motor activity and gastric emptying. Ital J Gastroenterol 1983; 15: 185-6
99. Batemen DN. The action of cisapride on gastric emptying and the pharmacokinetics of oral diazepam. Eur J Clin Pharmacol 1986; 30: 205-8
100. Jian R, Ducrot F, Piedloup C et al. Measurement of gastric emptying in dyspeptic patients: effect of a new gastrokinetic agent (Cisapride) Gut 1985; 26: 352-8
101. Dull JS, Rafuman J, Zakai MD, Strashun A, Straus EW. Successful treatment of gastroparesis with erythromycin in a patient with progressive systemic sclerosis. Am J Med 1990; 89 528-30
102. Ueberschaer B, Ewe K, Alles U, Schmidtmann I. Effect of 4 x 250 mg erythromycin on human gastrointestinal transit. Z Gastroenterol 1995, 33: 340-4
103. Janssens J, Peeters TL, Vantrappen G et al. Improvement of gastric emptying in diabetic gastroparesis by erythromycin, preliminary studies. N Engl J Med 1990; 322: 1028-31
104. Moller N Petrany G, Cassidy D et al Effects of the somatostatin analogue SMS 201-995 (sandostatin) on mouth-to-caecum transit time and absorption of fat and carbohydrates in normal man. Clin Science 1988. 75: 345-50
105. Witt K, Pedersen NT The long-acting somatostain analogue SMS 201-995 causes malabsorption. Scand J Gastroenterol 1989; 24 1248-52
106. Berlinger C Beeinflussung der exokrinen Pankreasfunktion durch Octreotide. Z Gastroenterol (suppl. 2) 1990; 28: 10-1
107. Compean DG, Jimenez JF, De La Garza FG et al. Octreotide therapy of large-volume refractory AIDS-associated diarrea: a randomized clinical trial AIDS 1994; 8: 1563-7
108. Layer P, Holtmann G. Octreotid bei intestinaler Pseudoobstruktion. Z Gastroenterol 1992; 30: 346-7
109. Toskes PP. Hope for the treatment of intestinal scteroderma. N Engl J Med 1991; 21: 1508
110. Kaye SA, Lim SG, Taylor M et al. Small bowel bacterial overgrowth in systemic sclerosis: detection using direct and indirect methods and treatment outcome. Br J Rheumatol 1995, 34: 265-9
111. Grabowski G, Gant JP. Nutritional support in patients with systemic scleroderma. J Parenter Enterai Nutr 1989; 13: 147-51
112. Barnett AJ, Taubmann I, Poon SK. Scleroderma (PSS) with severe bowel involvement, treatment by extensive resection of the small intestine. Aust N Z J Med 1976; 6: 470-3
113. Marshal I. Collagen disease of the small bowel. N Engl J Med 1956; 255: 978-80
114. Nash AG, Fountain R. Surgical presentation of systemic sclerosis of the small intestine. Br J Surg 1968; 55: 667-72
115. Reardon TM, Schnell GA, Smith OJ, Schubert TT. Surgical therapy of diabetic gastroparesis. J Clin Gastroenterol 1989; 11: 204-7
116. Orringer MB Surgical management of scleroderma reflux esophagitis. Surg Clin North Am 1983; 63: 859-76
117. Orringer MB, Dabich L, Zarafonetis CJD, Sloan H. Gastroesophageal reflux in esophageal scleroderma: diagnosis and implications Ann Thorac Surg 1976; 22: 120-30
118. Orringer MB, Orringer JS, Dabbich L, Zarafonetis CJ. Combined Collis gastroplasty fundoplication operations for scleroderma reflux esophagitis. Surgery 1981; 90: 624-30
119. Waters PF, DeMeesters TR. Foregut motor disorders and their management. Med Clin North Am 1981; 65: 1235-68